# Biogen Idec: portfolio, investments and team > Biogen Idec is a vc firm based in United States. 10 investments on record, latest Mar 2017. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/biogen-idec (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Biogen Idec Last cheque observed Mar 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet VC firm Seed Series A Series B Pharma Cgt Molecules Cheques on record **0%** of best year **0** **cheques in 12 months**, 10 on record Since the last cheque **3497** days **00** hrs **00** min **00** sec Median round **$50M** Rounds led **0 of 10** Sole investor **2 rounds** Exits **3 from the portfolio** Mostly in **United States, 100%** Pitch Biogen Idec ## Biogen Idec highlights - 01 10 rounds on record - 02 Mostly Series A and Series B: 70% of its rounds - 03 Sole investor in 2 rounds, median $3.8M - 04 3 exits from the portfolio ## What they do - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth - **Sectors:** Pharma Cgt Molecules - **Based in:** Weston, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **10 appearances** - **2017** 1 round - **Mar** **[Solid Biosciences](https://millionrounds.com/company/solid-biosciences)** Series C · US · FinSMEs **$50M** With 6 others - **2015** 1 round - **Nov** **[Solid Biosciences](https://millionrounds.com/company/solid-biosciences)** Series B · US **$43M** With 1 other - **2014** 1 round - **Mar** **[Ataxion](https://millionrounds.com/company/ataxion)** Series A · US **$17M** With 1 other - **2012** 1 round - **Sept** **[Museum of Science](https://millionrounds.com/company/museum-of-science)** Grant · US · masshightech.com **$1.0M** Sole investor - **2010** 1 round - **Nov** **[iPierian](https://millionrounds.com/company/ipierian)** Series B · US · fis.dowjones.com **$29M** With 7 others - **2009** 2 rounds - **Nov** **[Virdante Pharmaceuticals](https://millionrounds.com/company/virdante-pharmaceuticals)** Series A · US · onbiovc.com **$30M** With 6 others - **Jul** **[Intellikine](https://millionrounds.com/company/intellikine)** Series B · US · onbiovc.com **$51M** With 5 others - **2008** 2 rounds - **Mar** **[Provasculon](https://millionrounds.com/company/provasculon)** Series A · US · partners.org **$6.0M** With 1 other - **Jan** **[Escoublac](https://millionrounds.com/company/escoublac)** Series A · US **$6.7M** Sole investor - **2005** 1 round - **Oct** **[Raven Biotechnologies](https://millionrounds.com/company/raven-biotechnologies)** Series D · US · freshnews.com **$48M** With 11 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **2** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What they claim to have backed From their own portfolio page (on their website) **0** of 1 we have independently watched raise Colombia Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **3 in all** **[iPierian](https://millionrounds.com/company/ipierian)** Bought by [Bristol-Myers Squibb](https://millionrounds.com/fund/bristol-myers-squibb) **$175M** Apr 2014 **[Intellikine](https://millionrounds.com/company/intellikine)** Bought by [Takeda Pharmaceutical](https://millionrounds.com/fund/takeda-pharmaceutical) **$310M** Dec 2011 **[Raven Biotechnologies](https://millionrounds.com/company/raven-biotechnologies)** Bought by MacroGenics **Undisclosed** Jul 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. ## Companies it bought Acquisitions by the firm itself **[Convergence Pharmaceuticals](https://millionrounds.com/company/convergence-pharmaceuticals)** **$675M** Jan 2015 **[Stromedix](https://millionrounds.com/company/stromedix)** **$750M** Feb 2014 **Tysabri** **$3.3B** Feb 2013 **Syntonix** **$120M** Jan 2007 ## The cheque Seed Series A Series B Median round joined **$50M** the round, not its cheque Alone, median **$3.8M** Led 0 of 10 rounds **0%** - **Sole investor:** 2 rounds - **Last cheque:** Mar 2017 - **Exits:** 3 from the portfolio Rounds by stage said on their site - Series A said *4* - Series B said *3* - Grant *1* - Series C *1* - Series D *1* - Seed said *-* - Growth said *-* Cheques by year Led Joined 2005 2017 Often in the room with - [CMEA Ventures](https://millionrounds.com/fund/cmea-capital) 2 - [Mitsubishi UFJ Capital](https://millionrounds.com/fund/mitsubishi-ufj-capital-co-ltd) 2 - [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) 2 - [U.S. Venture Partners](https://millionrounds.com/fund/u-s-venture-partners-usvp) 2 **Pitching Biogen Idec?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Biogen Idec. A count of rooms they were both in, not a relationship either has claimed. [**CMEA Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/cmea-capital)[**Mitsubishi UFJ Capital** VC firm **2** rounds together](https://millionrounds.com/fund/mitsubishi-ufj-capital-co-ltd)[**Perceptive Advisors** Asset manager **2** rounds together](https://millionrounds.com/fund/perceptive-advisors)[**U.S. Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/u-s-venture-partners-usvp) ## Recently backed The latest companies Biogen Idec put money into. [**Solid Biosciences** $50M · Mar 2017](https://millionrounds.com/company/solid-biosciences) ## Quick answers about Biogen Idec ### What does Biogen Idec invest in? Biogen Idec invests most often at Series A and Series B (70% of the rounds on record), in sectors such as Pharma, Cgt and Molecules. ### How active is Biogen Idec? 10 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2017. ### What has Biogen Idec invested in recently? Its most recent investments on record: Solid Biosciences (Series C, Mar 2017). ### How big are Biogen Idec's cheques? The median round it joins is $50M. ### Does Biogen Idec lead rounds? Rarely, if at all: none of its 10 investments on record names it as the lead. ### Where does Biogen Idec invest? Most of the companies it backs are in the United States (100%). ### Is Biogen Idec investing now? No investments in the last 12 months; the latest was in Mar 2017. ### Who does Biogen Idec invest alongside? Most often CMEA Ventures (2 rounds together), Mitsubishi UFJ Capital (2 rounds together) and Perceptive Advisors (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=biogen-idec) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=biogen-idec)